User login
- /content/mogamulizumab-achieves-objective-responses-relapsed/refractory-adult-t-cell-leukemia
- /hematologynews/article/109566/aggressive-lymphomas/mogamulizumab-achieves-objective-responses
- /oncologypractice/article/109566/aggressive-lymphomas/mogamulizumab-achieves-objective-responses
- /hematologynews/nhlhub/article/109566/aggressive-lymphomas/mogamulizumab-achieves-objective-responses
- /hematology-oncology/article/109566/aggressive-lymphomas/mogamulizumab-achieves-objective-responses